Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients.
Sign Up to like & getrecommendations! Published in 2022 at "Open forum infectious diseases"
DOI: 10.1093/ofid/ofac677
Abstract: Antinucleocapsid (anti-N) immunoglobulin G antibody responses were lower in plasma and oral fluid after severe acute respiratory syndrome coronavirus 2 infection in vaccinated patients compared with patients infected before vaccination or infected without vaccination. This… read more here.
Keywords: infection; antinucleocapsid igg; reconsideration antinucleocapsid; antibody marker ... See more keywords